Jason Wittes
Stock Analyst at Roth MKM
(3.44)
# 968
Out of 4,915 analysts
62
Total ratings
51.85%
Success rate
4.68%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Buy | $405 → $456 | $392.73 | +16.11% | 11 | May 2, 2025 | |
| ALUR Allurion Technologies | Reiterates: Buy | $16 | $2.78 | +475.54% | 2 | Mar 21, 2025 | |
| MGRM Monogram Technologies | Maintains: Buy | $4 → $5.4 | $5.36 | +0.75% | 2 | Mar 18, 2025 | |
| FBIO Fortress Biotech | Reiterates: Buy | $15 → $16 | $1.85 | +764.86% | 3 | Mar 11, 2025 | |
| OFIX Orthofix Medical | Reiterates: Buy | $22 | $11.04 | +99.28% | 5 | Feb 26, 2025 | |
| IRMD IRADIMED CORPORATION | Reiterates: Buy | $60 → $72 | $58.34 | +23.41% | 3 | Feb 14, 2025 | |
| TLSI TriSalus Life Sciences | Reiterates: Buy | $11 | $4.26 | +158.22% | 2 | Jan 24, 2025 | |
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $52.63 | +118.51% | 4 | Dec 17, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $9.09 | +296.04% | 1 | Jul 24, 2024 | |
| DERM Journey Medical | Reinstates: Buy | $11 | $7.36 | +49.46% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.49 | +571.14% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $100 | $81.25 | +23.08% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.27 | +120.26% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $1.31 | +587.02% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $26.80 | +179.85% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $10.58 | +107.94% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $91.65 | +30.93% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $153.79 | +33.95% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $201.67 | -28.10% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $11.68 | +28.42% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $11.57 | +1,628.61% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $35.50 | -26.76% | 1 | Feb 22, 2017 |
Stryker
May 2, 2025
Maintains: Buy
Price Target: $405 → $456
Current: $392.73
Upside: +16.11%
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $2.78
Upside: +475.54%
Monogram Technologies
Mar 18, 2025
Maintains: Buy
Price Target: $4 → $5.4
Current: $5.36
Upside: +0.75%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15 → $16
Current: $1.85
Upside: +764.86%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $11.04
Upside: +99.28%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60 → $72
Current: $58.34
Upside: +23.41%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $4.26
Upside: +158.22%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $52.63
Upside: +118.51%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $9.09
Upside: +296.04%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $7.36
Upside: +49.46%
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.49
Upside: +571.14%
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $81.25
Upside: +23.08%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $2.27
Upside: +120.26%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $1.31
Upside: +587.02%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $26.80
Upside: +179.85%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $10.58
Upside: +107.94%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $91.65
Upside: +30.93%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $153.79
Upside: +33.95%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $201.67
Upside: -28.10%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $11.68
Upside: +28.42%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $11.57
Upside: +1,628.61%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $35.50
Upside: -26.76%